ArticleClinical drug investigation2025

A Cost-Effectiveness Analysis of Rivaroxaban Compared to Warfarin for the Management of Venous Thromboembolism in Western Kenya.

Emily T O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.